Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals
K. Kimura et al., Low-dose tissue plasminogen activator followed by planned rescue angioplasty reduces time to reperfusion for acute myocardial infarction treated at community hospitals, JPN CIRC J, 65(10), 2001, pp. 901-906
Citations number
23
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
The time from admission to reperfusion in patients with acute myocardial in
farction (AMI) was compared according to the type of hospital and treatment
strategy. A total of 164 patients with a first AMI within 12 h of onset we
re enrolled at one tertiary emergency center (TEC) and 6 community hospital
s (CHs). The subjects were randomly assigned to receive either primary perc
utaneous transluminal coronary angioplasty (PTCA) (TEC-primary PTCA and CHs
-primary PTCA groups) or 800,000 units of intravenous monteplase, half the
standard dose of a mutant tissue plasminogen activator (t-PA), followed by
rescue PTCA if the Thrombolysis in Myocardial Infarction (TIMI) flow grade
was 2 or less (TEC-monteplase and CHs-monteplase groups) on the first coron
ary angiogram. Sixty minutes after admission, TIMI flow grade 3 rates of th
e study groups were as follows, in descending order: TEC-monteplase group,
CHs-monteplase group, TEC-primary PTCA group, and CHs-primary PTCA group (5
6%, 41%, 36%, and 8%, respectively; p <0.01). However, there was no signifi
cant difference in the final TIMI flow grade 3 rate among the 4 groups. In
the CHs, the peak creatine kinase tended to be lower in the monteplase grou
p than in the primary PTCA group. The results suggest that low-dose montepl
ase followed by rescue PTCA is an effective strategy for promoting early re
perfusion in patients with AMI, especially those who are treated at CHs.